carbidopa

Italy

Drugs containing this active substance

  • CORBILTA

    It is used to treat Parkinson's disease, a condition caused by low levels of dopamine in the brain. Its active ingredients help increase dopamine levels and improve the effectiveness of symptom treatment.

    Form: tablets, film-coated

    Active substance Dosage
    entacapone -
    carbidopa -
    levodopa -

    ATC: N04BA03

    Manufacturer: ORION CORPORATION

  • It is used for the treatment of advanced Parkinson's disease, when oral medications are no longer sufficient.

    Form: gel, intestinal

    Active substance Dosage
    entacapone -
    carbidopa -
    levodopa -

    ATC: N04BA03

    Manufacturer: LOBSOR PHARMACEUTICALS AB

  • This medicine is used in adults to improve the signs of Parkinson's disease, such as slowness, instability, muscle stiffness, and tremors.

    Form: tablets

    Active substance Dosage
    carbidopa -
    levodopa -

    ATC: N04BA02

    Manufacturer: DOC GENERICI SRL

  • This medicine is used to treat Parkinson's disease, a condition caused by low levels of dopamine in the brain.

    Form: tablets, film-coated

    Active substance Dosage
    entacapone -
    carbidopa -
    levodopa -

    ATC: N04BA03

    Manufacturer: MYLAN S.P.A.

  • It is used to treat Parkinson's disease, a condition caused by low levels of dopamine in the brain. The medicine helps to increase the levels of this substance and reduce its symptoms.

    Form: tablets, film-coated

    Active substance Dosage
    entacapone -
    carbidopa -
    levodopa -

    ATC: N04BA03

    Manufacturer: ORION CORPORATION

  • It is used for the treatment of Parkinson's disease, a condition caused by low levels of dopamine in the brain.

    Form: tablets, film-coated

    Active substance Dosage
    entacapone -
    carbidopa -
    levodopa -

    ATC: N04BA03

    Manufacturer: TEVA ITALIA S.R.L.

  • Sinemet is used for the treatment of Parkinson's disease and parkinsonian syndrome. It is used to relieve symptoms such as muscle stiffness, slowness of movement (bradykinesia), tremor, difficulty swallowing, excessive saliva production, and instability in balance. Modified-release versions are specifically indicated to reduce complications in the advanced stage of the disease, such as muscle stiffness ('off' periods) in patients experiencing motor symptom fluctuations.

    Form: tablets

    Active substance Dosage
    levodopa -
    carbidopa -

    ATC: N04BA02

    Manufacturer: ORGANON ITALIA S.R.L.

  • It is used to treat Parkinson's disease, a condition caused by low levels of dopamine in the brain. Its active ingredients help increase dopamine levels and improve the effectiveness of the treatment.

    Form: tablets, film-coated

    Active substance Dosage
    entacapone -
    carbidopa -
    levodopa -

    ATC: N04BA03

    Manufacturer: ORION CORPORATION